GlassScriptPhysician profile
Shafeeq Ahmed
NPI 1275636300
$19,653.65
in general payments reported to CMS, 2019-2025
26 companies · $2,680 in 2025
The $2,680 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,283 · 2020: $405 · 2021: $107 · 2022: $2,283 · 2023: $2,212 · 2024: $11K · 2025: $2,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $11K · Food and Beverage: $3,203 · Travel and Lodging: $1,432 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $10,916.67 |
| Food and Beverage | $3,202.91 |
| Travel and Lodging | $1,432.37 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $10,916.67 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $2,334.80 | 2021-2025 | Abre, Ffrangio, Corevalve Evolut R |
| Boston Scientific Corporation | $2,324.49 | 2019-2025 | Watchman Flx, Watchman, Rotablator Rotational Atherectomy System Console Kit |
| Abbott Laboratories | $1,962.69 | 2019-2025 | Mitraclip, Triclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $502.09 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $465.41 | 2024-2025 | Lifevest |
| Shockwave Medical, INC | $192.78 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $127.60 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $90.94 | 2023-2025 | Eliquis, Camzyos |
| Cardiovascular Systems INC. | $90.53 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.08 | 2024-2025 | Jardiance |
| Amgen INC. | $86.86 | 2023-2024 | Repatha |
| W. L. Gore & Associates, INC. | $71.24 | 2023 | Gore Cardioform Septal Occluder |
| Cardiva Medical, INC. | $68.80 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bard Peripheral Vascular, INC. | $47.12 | 2025 | Venclose Maven Catheter |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $36.26 | 2024 | (Ck4) Mcot, (Br5) Peripheral Ivus |
| Pfizer INC. | $34.83 | 2024 | |
| Alnylam Pharmaceuticals INC. | $31.83 | 2024 | Onpattro |
| Impulse Dynamics (USA) INC. | $31.44 | 2023 | Optimizer |
| Heartflow, INC. | $25.06 | 2025 | |
| Merck Sharp & Dohme LLC | $24.67 | 2025 | Verquvo |
| Becton, Dickinson and Company | $23.24 | 2025 | Arista |
| Ge Healthcare | $20.46 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $20.11 | 2024 | |
| Elutia, INC. | $18.84 | 2023 | |
| Kestra Medical Technology Services, INC. | $15.81 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shafeeq Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.